Related Experiment Video
Updated: Jul 20, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.7K
Tuberculosis and stigma: Break the silence….
V K Arora1, K K Chopra2, Sanjay Rajpal2
1TB Association of India, 3 Red Cross Rd, Gokul Nagar, Sansad Marg Area, New Delhi, 110001, India.
The Indian Journal of Tuberculosis
|March 1, 2025
Summary
Social stigma surrounding diseases like tuberculosis (TB) and mental illness significantly hinders patient treatment adherence. Addressing these deep-rooted taboos is crucial for improving health outcomes and patient trust.
Area of Science:
- Medical Sociology
- Public Health
- Psychiatry
Background:
- Social stigma, deeply rooted in cultural taboos, negatively impacts patient care and treatment adherence for various diseases.
- Stigma erodes patient trust in healthcare providers, leading to decreased compliance with medical advice and follow-up care.
Discussion:
- Patients may avoid or delay necessary treatment due to fear of social repercussions, exacerbating disease management challenges.
- The impact of stigma is widespread, affecting not only infectious diseases like tuberculosis but also mental health conditions such as anxiety and depression.
Key Insights:
- Stigma is a significant barrier to effective disease management, affecting approximately 40% of mental illness cases.
- Reduced trust and poor treatment adherence are direct consequences of disease-related stigma.
- Overcoming stigma is essential for improving patient outcomes and ensuring equitable healthcare access.
Outlook:
- Future research should focus on developing and implementing culturally sensitive interventions to mitigate disease stigma.
- Public health initiatives are needed to raise awareness and challenge social taboos associated with various illnesses.
- Integrated care models addressing both the medical and psychosocial aspects of disease are vital for comprehensive patient support.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

